BUY MBP SECUKINUMAB SCAPHO 150 MG BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Secukinumab is a prescription medicine used to treat certain autoimmune and inflammatory conditions, including plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. It works by targeting a specific part of the immune system that causes inflammation, pain, and skin or joint damage.

Secukinumab is a monoclonal antibody that blocks a protein called interleukin-17A (IL-17A). IL-17A plays a major role in causing inflammation in autoimmune diseases. By blocking this protein, secukinumab reduces inflammation, relieves symptoms such as pain, swelling, stiffness, and skin plaques, and helps prevent further damage to joints and tissues.

Secukinumab is given as an injection under the skin. It is usually started with a loading phase, where injections are given once weekly for the first few weeks, followed by maintenance dosing once every four weeks. The injection can be given in the thigh, abdomen, or upper arm. Many patients are taught how to self-inject at home after proper training.

Before starting secukinumab, patients are usually screened for tuberculosis (TB) and other infections. This is because secukinumab affects the immune system and can increase the risk of infections or worsen existing ones. If you have an active infection, treatment may need to be delayed until it is resolved.

Common side effects include upper respiratory infections such as colds, sore throat, runny nose, headache, tiredness, and injection site reactions such as redness, swelling, or mild pain. These are usually mild and tend to improve with time.

More serious infections can occur, although they are less common. Symptoms such as persistent fever, chills, cough, shortness of breath, painful urination, or unexplained fatigue should be reported immediately. Because secukinumab affects the immune system, the body may not fight infections as effectively as usual.

Some people may experience worsening of inflammatory bowel disease, such as Crohn?s disease or ulcerative colitis. If symptoms such as persistent diarrhoea, abdominal pain, or blood in the stool occur, medical attention should be sought.

Allergic reactions are rare but can occur. Signs include swelling of the face or throat, difficulty breathing, rash, or severe itching. This requires urgent medical attention.

Live vaccines should not be given while using secukinumab. It is important to discuss vaccinations with a healthcare provider before starting treatment. Inactivated vaccines are generally safe.

Secukinumab should be used with caution during pregnancy and breastfeeding. If you are planning a pregnancy or become pregnant while on treatment, inform your healthcare provider immediately.

This medicine does not cure autoimmune disease, but it can significantly reduce symptoms, improve quality of life, and slow disease progression when used consistently. Many patients experience noticeable improvement within the first few weeks of treatment.

Regular follow-up appointments are important to monitor response, manage side effects, and ensure ongoing safety. When used correctly under medical supervision, secukinumab is an effective and well-tolerated treatment for chronic inflammatory conditions.